# Arbutus Biopharma Corp: Form 8-K, filed Feb 14, 2019

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2019-02-14
- Accepted by EDGAR: Feb 13, 2019, 17:55 ET
- Period: 2019-02-13
- Accession: 0001104659-19-008025
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000110465919008025/a19-3768_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000110465919008025/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000110465919008025/a19-3768_18k.htm

Filed Feb 14, 2019.
Source: SEC EDGAR, the filing index for accession 0001104659-19-008025. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.